Crinetics Pharmaceuticals reported cash from operations of -$94.19M and free cash flow of -$94.71M for the quarter ended Jun 2026, down 9.7% year over year. This cash flow statement covers 37 quarters of results from Jun 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||||||
| Net Income | 27.85M | -184.49M | 33.62M | 42.38M | 41.92M | 44.99M | 45.99M | 50.98M | 56.46M | -362.77M | 66.46M | 74.06M | -76.83M | -80.59M | 96.77M | 115.64M | -130.09M | -122.64M | -127.71M | -120.43M | |||||||||||||||||
| Share-based Compensation | 4.55M | 5.16M | 7.98M | 8.52M | 8.90M | 7.95M | 11.54M | 12.42M | 12.46M | 11.62M | 14.46M | 18.94M | 18.15M | 18.84M | 20.48M | 26.12M | 22.70M | 21.72M | 29.68M | 24.88M | |||||||||||||||||
| Deferred Taxes | |||||||||||||||||||||||||||||||||||||
| Cash from Operations | -25.67M | -22.90M | -13.54M | -27.98M | -38.48M | -35.21M | -40.72M | -45.73M | -41.34M | -40.81M | -52.86M | -47.64M | -62.82M | -66.87M | -88.45M | -85.85M | -110.72M | -92.90M | -124.70M | -94.19M | |||||||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||||||||
| Amortizatization of Intangibles | -0.07M | -0.19M | -0.32M | -0.20M | 0.13M | 0.35M | 0.53M | 0.91M | 1.25M | 3.58M | 3.85M | 3.41M | 3.51M | 4.16M | 4.38M | 4.71M | 3.60M | 2.73M | 2.22M | 2.02M | |||||||||||||||||
| Amortization of Deferred Charges | |||||||||||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.23M | 0.23M | 0.24M | 0.21M | 0.25M | 0.28M | 0.28M | 0.28M | 0.27M | 0.26M | 0.47M | 0.75M | 0.77M | 0.79M | 0.93M | 0.96M | 1.01M | 0.99M | 1.16M | 1.07M | |||||||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||||||||
| Change in Receivables | 5.09M | 6.27M | |||||||||||||||||||||||||||||||||||
| Change in Inventory | 0.91M | 0.36M | |||||||||||||||||||||||||||||||||||
| Change in Accured Expenses | 0.49M | 3.90M | 1.53M | 6.71M | -1.33M | 4.08M | -1.34M | 7.42M | 4.38M | 1.90M | 1.31M | 5.21M | 0.69M | 6.12M | -1.36M | 12.52M | 6.65M | 11.18M | -12.06M | 9.29M | |||||||||||||||||
| Other Working Capital Changes | 3.06M | 0.36M | -2.49M | -0.74M | 2.18M | 0.11M | -1.52M | 11.00M | -1.12M | -3.85M | 0.78M | -4.67M | 2.06M | 7.80M | 6.92M | 4.41M | 7.21M | -2.02M | 7.02M | 0.46M | |||||||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||||||||
| Capital Expenditures | 0.14M | 0.02M | 0.09M | 0.61M | 0.68M | 0.27M | 0.03M | 0.22M | 3.50M | 0.94M | 1.33M | 0.95M | 0.53M | 1.03M | 1.24M | 3.20M | 0.86M | 0.46M | 0.82M | 0.52M | |||||||||||||||||
| Change in Acquisitions & Divestments | 13.96M | 0.24M | 11.72M | 18.90M | 56.19M | 70.69M | 71.44M | 91.17M | 87.84M | 86.68M | 101.38M | 139.30M | 151.15M | 183.97M | 306.48M | 224.03M | 382.37M | 271.21M | 302.89M | 182.03M | |||||||||||||||||
| Cash from Investing Activities | -7.03M | -101.80M | -43.38M | -174.27M | 6.82M | 36.85M | 48.76M | 31.44M | -193.30M | -87.31M | 0.31M | -53.64M | 20.60M | -542.09M | -85.96M | 37.95M | 164.81M | 57.11M | -252.36M | 26.29M | |||||||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||||||||
| Other financing activities | 0.49M | 1.85M | 1.78M | 1.74M | 1.09M | 0.12M | 0.48M | 1.12M | -10.73M | 10.36M | 2.03M | 10.68M | -32.88M | 4.44M | 2.88M | 3.08M | -14.58M | 9.94M | 8.93M | ||||||||||||||||||
| Debt Issuance and Repayment | |||||||||||||||||||||||||||||||||||||
| Long-Term Debt Issuances | |||||||||||||||||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 2,889.00M | 1.65M | 4,139.20M | 2.17M | 4.82M | 2.52M | 3.97M | 2.15M | |||||||||||||||||||||||||||||
| Net Equity Issued and Repurchased | 14.98M | 162.01M | -0.01M | 11.31M | 328.96M | 29.29M | 383.21M | 48.30M | 543.53M | 380.51M | |||||||||||||||||||||||||||
| Misc. | |||||||||||||||||||||||||||||||||||||
| Cash from Financing Activities | 15.46M | 163.86M | 1.78M | 118.99M | 1.08M | 0.12M | 0.48M | 12.66M | 337.88M | 40.22M | 393.57M | 7.52M | 57.33M | 556.24M | 4.44M | 7.05M | 3.08M | 26.04M | 389.88M | 8.93M | |||||||||||||||||
| Exchange Rate Effect | -0.01M | 0.13M | |||||||||||||||||||||||||||||||||||
| Change in Cash | -17.23M | 39.16M | -55.15M | -83.25M | -30.58M | 1.76M | 8.52M | -1.64M | 103.24M | -87.90M | 341.03M | -93.76M | 15.11M | -52.72M | -169.98M | -40.84M | 57.17M | -9.76M | 12.81M | -58.98M | |||||||||||||||||
| Free Cash Flow | -25.81M | -22.92M | -13.63M | -28.59M | -39.16M | -35.48M | -40.75M | -45.95M | -44.84M | -41.74M | -54.19M | -48.60M | -63.35M | -67.90M | -89.69M | -89.05M | -111.58M | -93.36M | -125.52M | -94.71M | |||||||||||||||||
| Net Cash Flow | -17.23M | 39.16M | -55.15M | -83.25M | -30.58M | 1.76M | 8.52M | -1.64M | 103.24M | -87.90M | 341.03M | -93.76M | 15.11M | -52.72M | -169.98M | -40.84M | 57.17M | -9.76M | 12.81M | -58.98M |